骨肉瘤MG63细胞中VEGF-C/VEGFR-3/iNOS信号转导对人脐静脉内皮细胞增殖的促进作用

Your Location：

Home >

Browse articles >

骨肉瘤MG63细胞中VEGF-C/VEGFR-3/iNOS信号转导对人脐静脉内皮细胞增殖的促进作用

中国医学科学杂志（英文版） 2021年36卷第1期页码：35-42

论著 | Updated：2024-04-10

|

- 骨肉瘤MG63细胞中VEGF-C/VEGFR-3/iNOS信号转导对人脐静脉内皮细胞增殖的促进作用
- Affiliations：
  
  Department of Orthopaedics, the Second Hospital of Shanxi Medical University, Taiyuan 030001, China
- Author bio：
  
  * Yongfeng Wang, E-mail: wyfwf8@163.com
- Funds：
  
  Funded by the Natural Science Fundation of Shanxi Province;山西省自然科学基金(201801D121220)
- DOI：10.24920/003753
  中图分类号：
- 收稿日期：2020-04-11，
  
  录用日期：2020-5-14，
  
  网络出版日期：2021-02-07，
  
  纸质出版日期：2021-02-07
- Accepted：
Scan QR Code
吕杰, 原杰, 徐朝健, 等. 骨肉瘤MG63细胞中VEGF-C/VEGFR-3/iNOS信号转导对人脐静脉内皮细胞增殖的促进作用[J]. 中国医学科学杂志（英文版）, 2021,36(1):35-42.

Lv Jie, Yuan Jie, Xu Chaojian, et al. VEGF-C/VEGFR-3/iNOS Signaling in Osteosarcoma MG63 Cells Mediates Stimulatory Effects on Human Umbilical Vein Endothelial Cell Proliferation[J]. Chinese medical sciences journal, 2021, 36(1): 35-42.
吕杰, 原杰, 徐朝健, 等. 骨肉瘤MG63细胞中VEGF-C/VEGFR-3/iNOS信号转导对人脐静脉内皮细胞增殖的促进作用[J]. 中国医学科学杂志（英文版）, 2021,36(1):35-42. DOI： 10.24920/003753.

Lv Jie, Yuan Jie, Xu Chaojian, et al. VEGF-C/VEGFR-3/iNOS Signaling in Osteosarcoma MG63 Cells Mediates Stimulatory Effects on Human Umbilical Vein Endothelial Cell Proliferation[J]. Chinese medical sciences journal, 2021, 36(1): 35-42. DOI： 10.24920/003753.

摘要

目的

探讨血管内皮生长因子-C（vascular endothelial growth factor-C

VEGF-C）/血管内皮生长因子受体-3（vascular endothelial growth factor receptor-3

VEGFR-3）信号转导对人骨肉瘤MG63细胞中一氧化氮（nitric oxide

NO）的生成和诱导型一氧化氮合酶（inducible nitric oxide synthase

iNOS）的表达以及对人脐静脉内皮细胞（human umbilical vein endothelial cells

HUVECs）增殖的影响。

方法

MG63细胞分别以VEGF-C单独处理（VEGF-C组）

VEGF-C联合iNOS抑制剂氨基胍AG（AG组）以及VEGF-C联合VEGFR-3抑制剂MAZ-51（MAZ-51组）处理

将未处理的MG63细胞作为对照。采用硝酸还原酶比色法测定NO生成量

逆转录-聚合酶链反应（reverse transcription polymerase chain reaction

RT-PCR）和Western blot分别检测iNOS的mRNA和蛋白水平。为研究MG63细胞中VEGF-C/VEGFR-3/iNOS信号通路对HUVECs增殖的影响

实验设立如下6组：HUVECs组、HUVECs+MG63组、HUVECs+VEGF-C组、HUVECs+MG63+VEGF-C组、HUVECs+MG63+VEGF-C+AG组及HUVECs+MG63+VEGF-C+MAZ51组。用细胞计数试剂盒（Cell Counting Kit-8

CCK-8）、5-乙炔基-2'-脱氧尿嘧啶核苷（5 ethynyl 2' deoxyuridine

EdU）掺入法和增殖细胞核抗原（proliferating cell nuclear antigen

PCNA）定量表达评估各组HUVECs的增殖情况。

结果

VEGF-C促进了MG63细胞中iNOS在基因（LSD-

t

=4.152

P

<

0.01）和蛋白水平的表达（LSD-

t

=3.486

P

<

0.01）

增加了NO释放（LSD-

t

=3.774

P

<

0.01）。经AG或MAZ51处理均可降低上述作用（mRNA：LSD-

t

=9.183

P

<

0.001;LSD-

t

=8.639

P

<

0.001;protein：LSD-

t

=5.170

P

<

0.001;LSD-

t

=7.255

P

<

0.001;NO：LSD-

t

=10.326

P

<

0.001;LSD-

t

=10.540

P

<

0.001）。HUVECs与MG63细胞和/或VEGF-C共同培养可显著促进HUVECs的增殖（EdU：LSD-

t

=5.374

P

<

0.001;LSD-

t

=2.984

P

<

0.05;LSD-

t

=8.526

P

<

0.001;PCNA： LSD-

t

=9.267

P

<

0.001;LSD-

t

=5.515

P

<

0.001;LSD-

t

=14.873

P

<

0.001）。经AG（EdU：LSD-

t

=10.770

P

<

0.001;PCNA：LSD-

t

=19.940

P

<

0.001）或MAZ51（EdU：LSD-

t

=6.950

P

<

0.001;PCNA：LSD-

t

=14.001

P

<

0.001）处理后

MG63细胞和VEGF-C对HUVECs增殖的诱导作用减弱。

结论

VEGF-C激活VEGFR-3可促进在人骨肉瘤MG63细胞iNOS的表达和NO的产生

进而诱导HUVECs的增殖。

Abstract

Objective

To assess the effects of vascular endothelial growth factor-C (VEGF-C)/vascular endothelial growth factor receptor-3 (VEGFR-3) signaling on nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression in human osteosarcoma MG63 cells and the subsequent impact on the proliferation of human umbilical vein endothelial cells (HUVECs).

Methods

MG63 cells were treated with VEGF-C alone (VEGF-C group)

VEGF-C + iNOS inhibitor aminoguanidine (AG; AG group)

and VEGF-C + VEGFR-3 inhibitor MAZ51 (MAZ51 group); untreated MG63 cells were used as controls. NO production was evaluated by a colorimetric method involving nitrate reductase. Meanwhile

mRNA and protein levels of iNOS were examined by reverse transcription polymerase chain reaction (RT-PCR) and Western blot. To explore the effect of VEGF-C/VEGFR-3/iNOS signaling of MG63 cells on proliferation of HUVECs

we set up six groups: HUVECs

HUVECs+MG63

HUVECs+VEGF-C

HUVECs+MG63+VEGF-C

HUVECs+MG63+VEGF-C+AG

and HUVECs+MG63+VEGF-C+MAZ51 groups. The proliferation of HUVEC cells was assessed by Cell Counting Kit-8 (CCK-8)

5-ethynyl-2’-deoxyuridine (EdU) incorporation assay

and proliferating cell nuclear antigen (PCNA) expression quantitation.

Results

VEGF-C treatment enhanced iNOS expression at both gene and protein levels (mRNA: LSD-

t

=4.152

P<0.01

; protein: LSD-

t

=3.486

P<0.01

) and increased NO release of MG63 cells (LSD-

t

=3.774

P<0.01

); treatment with either AG or MAZ51 decreased these effects (mRNA: LSD-

t

=9.183

P

<

0.001; LSD-

t

=8.639

P

<

0.001; protein: LSD-

t

=5.170

P

<

0.001; LSD-

t

=7.255

P

<

0.001; NO production:LSD-

t

=10.326

P

<

0.001; LSD-

t

=10.540

P

<

0.001). Interestingly

co-incubation of HUVECs with MG63 cells and/or VEGF-C significantly promoted HUVEC proliferation (EdU: LSD-

t

=5.374

P<

0.001; LSD-

t

=2.984

P<

0.05; LSD-

t

=8.526

P<

0.001; PCNA: LSD-

t

=9.267

P

<

0.001; LSD-

t

=5.515

P<

0.001; LSD-

t

=14.873

P<

0.001).The proliferation effects of HUVEC induced by MG63 cells and VEGF-C attenuated by the treatment of AG (EdU: LSD-

t

=10.770

P<

0.001; PCNA: LSD-

t

=19.940

P

<

0.001) or MAZ51 (EdU: LSD-

t

=6.950

P<

0.001; PCNA: LSD-

t

=14.001

P

<

0.001).

Conclusion

In human osteosarcoma MG63 cells

activation of VEGFR-3 by VEGF-C promotes iNOS expression and NO production

which subsequently induces HUVEC proliferation.

关键词

Keywords

references

Messerschmitt PJ , Garcia RM , Abdul-Karim FW , et al . Osteosarcoma . J Am Acad Orthop Surg 2009 ; 17 ( 8 ): 515 - 27 . doi: 10.1097/BSD.0b013e31818d5fcb 1001-9294-36-1-35/BSD.0b013e31818d5fcb .

Dai Z , Tang H , Pan Y , et al . Gene expression profiles and pathway enrichment analysis of human osteosarcoma cells exposed to sorafenib . FEBS Open Bio 2018 ; 8 ( 5 ): 860 - 7 . doi: 10.1002/2211-5463.12428 1001-9294-36-1-35/2211-5463.12428 .

Hameed M , Mandelker D . Tumor syndromes predisposing to osteosarcoma . Adv Anat Pathol 2018 ; 25(4):217-22 . doi: 10.1097/PAP.0000000000000190 1001-9294-36-1-35/PAP.0000000000000190 .

Wang J , Cao L , Wu J , et al . Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma . Int J Oncol 2018 ; 52 ( 1 ): 77 - 88 . doi: 10.3892/ijo.2017.4187 1001-9294-36-1-35/ijo.2017.4187 .

Nieto-Coronel MT , López-Vásquez AD , Marroquín-Flores D , et al . Central nervous system metastasis from osteosarcoma: Case report and literature review . Rep Pract Oncol Radiother 2018 ; 23 ( 4 ): 266 - 9 . doi: 10.1016/j.rpor.2018.06.003 1001-9294-36-1-35/j.rpor.2018.06.003 . DOI: 10.1016/j.rpor.2018.06.003 http://doi.org/10.1016/j.rpor.2018.06.003 https://www.ncbi.nlm.nih.gov/pubmed/30090025 https://www.ncbi.nlm.nih.gov/pubmed/30090025

Harrison DJ , Geller DS , Gill JD , et al . Current and future therapeutic approaches for osteosarcoma . Expert Rev Anticancer Ther 2018 ; 18 ( 1 ): 39 - 50 . doi: 10.1080/14737140.2018.1413939 1001-9294-36-1-35/14737140.2018.1413939 .

Briccoli A , Rocca M , Salone M , et al . Resection of recurrent pulmonary metastases in patients with osteosarcoma . Cancer 2005 ; 104 ( 8 ): 1721 - 25 . doi: 10.1002/cncr.21369 1001-9294-36-1-35/cncr.21369 .

Hanahan D , Weinberg RA . Hallmarks of cancer: the next generation . Cell 2011 ; 144 ( 5 ): 646 - 74 . doi: 10.1016/j.cell.2011.02.013 1001-9294-36-1-35/j.cell.2011.02.013 .

Segaliny AI , Mohamadi A , Dizier B , et al . Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment . Int J Cancer 2015 ; 137 ( 1 ): 73 - 85 . doi: 10.1002/ijc.29376 1001-9294-36-1-35/ijc.29376 .

Yang X , Zhou W , Liu S . SPAG9 controls the cell motility, invasion and angiogenesis of human osteosarcoma cells . Exp Ther Med 2016 ; 11 ( 2 ): 637 - 44 . doi: 10.3892/etm.2015.2932 1001-9294-36-1-35/etm.2015.2932 .

Qu W , Wang Y , Wu Q , et al . Emodin inhibits HMGB1induced tumor angiogenesis in human osteosarcoma by regulating SIRT1 . Int J Clin Exp Med 2015 ; 8 ( 9 ): 15054 - 64 .

Kimura Y , Sumiyoshi M . Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis . Phytomedicine 2013 ; 20 ( 3-4 ): 328 - 36 . doi: 10.1016/j.phymed.2012.10.016 1001-9294-36-1-35/j.phymed.2012.10.016 .

Folkman J . What is the role of endothelial cells in angiogenesis? Lab Invest 1984 ; 51 ( 6 ): 601 - 4 .

Dong Z , Nor JE . Transcriptional targeting of tumor endothelial cells for gene therapy . Adv Drug Deliv Rev 2009 ; 61 ( 7-8 ): 542 - 53 . doi: 10.1016/j.addr.2009.02.006 1001-9294-36-1-35/j.addr.2009.02.006 . DOI: 10.1016/j.addr.2009.02.006 http://doi.org/10.1016/j.addr.2009.02.006 https://www.ncbi.nlm.nih.gov/pubmed/19393703 https://www.ncbi.nlm.nih.gov/pubmed/19393703

Kang JX , Liu A . The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis . Cancer Metastasis Rev 2013 ; 32 ( 1-2 ): 201 - 10 . doi: 10.1007/s10555-012-9401-9 1001-9294-36-1-35/s10555-012-9401-9 . https://www.ncbi.nlm.nih.gov/pubmed/23090260 https://www.ncbi.nlm.nih.gov/pubmed/23090260

Zhao J , Zhang ZR , Zhao N , et al . VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathway . Int J Clin Exp Med 2015 ; 8 ( 8 ): 12411 - 7 . doi: 10.1007/s12013-015-0692-7 1001-9294-36-1-35/s12013-015-0692-7 . https://www.ncbi.nlm.nih.gov/pubmed/26550152 https://www.ncbi.nlm.nih.gov/pubmed/26550152

Abdeen A , Chou AJ , Healey JH , et al . Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma . Cancer 2009 ; 115 ( 22 ): 5243 - 50 . doi: 10.1002/cncr.24562 1001-9294-36-1-35/cncr.24562 .

Park HR , Min K , Kim HS , et al . Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas . Pathol Res Pract 2008 ; 204 ( 8 ): 575 - 82 . doi: 10.1016/j.prp.2008.01.015 1001-9294-36-1-35/j.prp.2008.01.015 .

Chien MH , Ku CC , Johansson G , et al . Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway . Carcinogenesis 2009 ; 30 ( 12 ): 2005 - 13 . doi: 10.1093/carcin/bgp244 1001-9294-36-1-35/carcin/bgp244 .

Curiel TJ , Cheng P , Mottram P , et al . Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer . Cancer Res 2004 ; 64 ( 16 ): 5535 - 8 . doi: 10.1158/0008-5472.CAN-04-1272 1001-9294-36-1-35/0008-5472.CAN-04-1272 .

Lahdenranta J , Hagendoorn J , Padera TP , et al . Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis . Cancer Res 2009 ; 69 ( 7 ): 2801 - 8 . doi: 10.1158/0008-5472.CAN-08-4051 1001-9294-36-1-35/0008-5472.CAN-08-4051 . https://www.ncbi.nlm.nih.gov/pubmed/19318557 https://www.ncbi.nlm.nih.gov/pubmed/19318557

Fukumura D , Kashiwagi S , Jain RK . The role of nitric oxide in tumour progression . Nat Rev Cancer 2006 ; 6 ( 7 ): 521 - 34 . doi: 10.1038/nrc1910 1001-9294-36-1-35/nrc1910 .

Chen WL , Feng HJ , Li JS , et al . Expression and pathological relevance of inducible nitric oxide synthase in osteosarcoma of the jaws . Int J Oral Maxillofac Surg 2007 ; 36 ( 6 ): 541 - 4 . doi: 10.1016/j.ijom.2007.02.012 1001-9294-36-1-35/j.ijom.2007.02.012 .

Cullis ER , Kalber TL , Ashton SE , et al . Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the antitumour effects of the vascular disrupting agent ZD6126 . Microvasc Res 2006 ; 71 ( 2 ): 76 - 84 . doi: 10.1016/j.mvr.2006.01.004 1001-9294-36-1-35/j.mvr.2006.01.004 . https://www.ncbi.nlm.nih.gov/pubmed/16530791 https://www.ncbi.nlm.nih.gov/pubmed/16530791

Ellie E , Loiseau H , Lafond F , et al . Differential expression of inducible nitric oxide synthase mRNA in humanbrain tumours . Neuroreport 1995 ; 7 ( 1 ): 294 - 6 . doi: 10.1097/00001756-199512290-00070 1001-9294-36-1-35/00001756-199512290-00070 . https://www.ncbi.nlm.nih.gov/pubmed/8742473 https://www.ncbi.nlm.nih.gov/pubmed/8742473

Loibl S , Buck A , Strank C , et al . The role of early expression of inducible nitric oxide synthase in human breast cancer . Eur J Cancer 2005 ; 41 ( 2 ): 265 - 71 . doi: 10.1016/j.ejca.2004.07.010 1001-9294-36-1-35/j.ejca.2004.07.010 . https://www.ncbi.nlm.nih.gov/pubmed/15661552 https://www.ncbi.nlm.nih.gov/pubmed/15661552

Ekmekcioglu S , Ellerhorst JA , Prieto VG , et al . Tumor iNOS predicts poor survival for stage III melanoma patients . Int J Cancer 2006 ; 119 ( 4 ): 861 - 6 . doi: 10.1002/ijc.21767 1001-9294-36-1-35/ijc.21767 . DOI: 10.1002/ijc.21767 http://doi.org/10.1002/ijc.21767 https://www.ncbi.nlm.nih.gov/pubmed/16557582 https://www.ncbi.nlm.nih.gov/pubmed/16557582

Dias S , Choy M , Alitalo K , et al . Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy . Blood 2002 ; 99 ( 6 ): 2179 - 84 . doi: 10.1182/blood.V99.6.2179 1001-9294-36-1-35/blood.V99.6.2179 . DOI: 10.1182/blood.v99.6.2179 http://doi.org/10.1182/blood.v99.6.2179 https://www.ncbi.nlm.nih.gov/pubmed/11877295 https://www.ncbi.nlm.nih.gov/pubmed/11877295

Watanabe T , Sugaya M , Atkins AM , et al . Kaposi’s sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells . J Virol 2003 ; 77 ( 11 ): 6188 - 96 . doi: 10.1128/JVI.77.11.6188-6196.2003 1001-9294-36-1-35/JVI.77.11.6188-6196.2003 .

0

浏览量

733

Downloads

0

CSCD

>

文章被引用时，请邮件提醒。

Submit

关联资源

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据

⁰